Etoposide

This is a powerful medicine used to treat certain types of cancer. It works by stopping cancer cells from dividing and growing. It's a type of chemotherapy drug.

Brand names:Eposin, Toposar, Vepesid
Medication

What people taking Etoposide report

Every report comes from a Lived member, sent anonymously.

Have you tried Etoposide for Small Cell Lung Cancer?

NameHow it went

About Etoposide

What It's For

Etoposide is a chemotherapy medicine used to treat cancer, almost always in combination with other cancer drugs rather than on its own. In the US it is approved as part of first-line treatment for small cell lung cancer, a fast-growing type of lung cancer, and for testicular cancer that has kept growing or come back after earlier treatment with surgery, chemotherapy and radiation. In practice its role is broader. Combined with bleomycin and cisplatin in a regimen known by their initials as BEP, it is a standard first treatment for testicular and other germ cell cancers (cancers that start in the cells that form sperm or eggs, most often in the testicles or ovaries) that have spread, given with the aim of cure. For small cell lung cancer it is usually paired with a platinum drug (cisplatin or carboplatin), and for advanced disease that pairing is now often given together with an immunotherapy drug. Oncologists also use etoposide off-label (for uses outside its formal approval) for some lymphomas and leukemias, certain childhood cancers such as neuroblastoma and Wilms tumor (a childhood kidney cancer), and some other cancers. Etoposide comes as an intravenous (IV) solution, sold mainly as a generic; as Etopophos (etoposide phosphate, a form that dissolves more easily for IV use); and as VePesid capsules taken by mouth. Toposar is a former brand name for the injection. The capsules are approved only for small cell lung cancer.

How It Works

Before a cell divides, it has to copy its DNA, and the long DNA strands must be untangled as they are copied. An enzyme called topoisomerase II does this by briefly cutting through both strands of DNA and then sealing the cut again. Etoposide binds to the enzyme and the DNA together, so the cuts are left open instead of being repaired. A cell that builds up too many breaks in its DNA cannot complete division and dies. Rapidly dividing cells are the most exposed to this effect, which is why etoposide is useful against fast-growing cancers such as small cell lung cancer and germ cell tumors. The same effect reaches healthy cells that divide quickly, particularly in the bone marrow, the hair follicles and the lining of the mouth and gut, and that explains its main side effects.

Dosage & Administration

Etoposide is dosed by body surface area, a figure calculated from height and weight, and given in cycles: a few days of treatment followed by a break so the body, especially the blood counts, can recover. Cycles are usually repeated every three to four weeks. The exact schedule depends on the cancer, the other drugs in the regimen, kidney function, earlier radiation or chemotherapy, and how well previous cycles were tolerated. The IV form is given in a clinic or hospital, commonly on several consecutive days of each cycle. Standard etoposide solution is run in slowly, usually over 30 to 60 minutes, because a rapid injection can cause a drop in blood pressure. Etopophos can be given much faster, over as little as 5 minutes, or more slowly if needed. Capsules are usually taken once a day for four or five days in a row in each cycle, at about the same time each day. The capsule dose is roughly twice the IV dose, so the two forms are not interchangeable milligram for milligram. Capsules are kept in the refrigerator, and anyone handling the blister pack should wear gloves to avoid skin contact with the drug. A missed capsule is generally taken when remembered unless the next dose is nearly due; never take two doses together, and check with the cancer team if unsure.

Side Effects

The most important effect is on the bone marrow, which makes blood cells. White blood cells, which fight infection, typically fall to their lowest level about 7 to 14 days after a dose, and platelets, which help blood clot, about 9 to 16 days after. Counts usually recover by around day 20, which is why cycles are spaced weeks apart and blood counts are checked before each one. While counts are low, an infection can become serious quickly. Call the cancer care team right away for a fever, sore throat, ongoing cough or other signs of infection, and for unusual bleeding or bruising, black or tarry stools, or vomit that contains blood or looks like coffee grounds. Nausea and vomiting are common but usually mild to moderate, and anti-nausea medicine given with treatment controls them for most people; they are somewhat more frequent with the capsules. Hair loss is common and can be complete, but it is reversible. Loss of appetite, mouth sores, diarrhea, tiredness and, less often, tingling in the hands and feet can also occur. In combination regimens, the other drugs bring side effects of their own. Allergic-type reactions occur in up to about 2 in 100 people receiving etoposide by IV, sometimes during the very first infusion. Signs include chills, fever, a racing heart, wheezing, shortness of breath or feeling faint from low blood pressure. Tell the nurse at once if any of these start during an infusion; it can be stopped and the reaction treated. Away from the clinic, trouble breathing or swallowing, or swelling of the face or tongue, needs emergency care.

Interactions & Warnings

Etoposide can seriously harm a developing baby. People who could become pregnant should use effective contraception during treatment and for 6 months after the last dose, and anyone who becomes pregnant during treatment should tell the team promptly. Because etoposide can also damage sperm, men with a partner who could become pregnant should use effective contraception during treatment and for 4 months after the last dose. Breastfeeding is not recommended while receiving etoposide. Etoposide can also reduce fertility. In men it can lower or stop sperm production, sometimes permanently, although sperm counts return to normal in some men, occasionally years after treatment. In women it can stop periods and cause infertility or early menopause, and whether periods and ovulation return depends partly on age. Banking sperm or freezing eggs is usually done before treatment starts, so it is worth raising before the first cycle. The kidneys clear much of the drug, so the dose is lowered for people with reduced kidney function. Older adults and people with low blood albumin (the protein that carries etoposide in the bloodstream) tend to have stronger side effects, especially on blood counts, and earlier radiation or chemotherapy that has weakened the bone marrow is also taken into account. Only a few drug interactions are well documented. In people taking the blood thinner warfarin, etoposide can raise the INR (international normalized ratio, a blood test of how long blood takes to clot), adding to the bleeding risk while platelets are low, so INR is checked more often. Anyone on warfarin should make sure the team managing it knows etoposide is starting. High-dose cyclosporine, an immune-suppressing drug used after transplants, can raise etoposide levels and so strengthen its side effects, which is why the team needs to know about it. Aspirin also thins the blood and may affect how etoposide is carried in the blood, so check with the team before taking it, especially when platelet counts are low. Because the drugs given alongside etoposide have their own interactions, give the team a full list of prescriptions, over-the-counter medicines and supplements before starting. Rarely, etoposide has been linked to acute leukemia that develops after treatment, a blood cancer caused by the chemotherapy itself. How large that risk is remains unclear. It is a recognized trade-off of treatment and one reason follow-up continues after the original cancer is treated.

What to Expect

Etoposide is one part of a planned course, with the number of cycles set at the start according to the cancer and the regimen. Each cycle has a rhythm: the treatment days, a stretch about one to two weeks later when blood counts are lowest and infection risk is highest, and then a recovery period before the next cycle. Blood tests before each cycle decide whether it can start on time. If counts have not recovered, the next cycle is delayed or the dose adjusted, which is a routine safety step rather than a sign that treatment is failing. The aim differs by cancer. Testicular and other germ cell cancers are often curable with etoposide-based chemotherapy, even when they have spread. Small cell lung cancer that has spread widely has a much more serious outlook, and treatment usually aims to shrink the cancer and keep it controlled for as long as possible. Scans during and after treatment show how the cancer is responding. Hair and blood counts generally recover in the weeks after the last cycle. Follow-up continues afterward, both to watch for the original cancer and for late effects of treatment.

Questions to Ask Your Doctor

  1. 1.What is the goal of this regimen for my cancer, and how will we know whether it is working?
  2. 2.Which drugs will be given with etoposide, and which side effects come from each of them?
  3. 3.When in each cycle will my blood counts be lowest, and who do I call, including after hours, if I get a fever?
  4. 4.Could this treatment affect my fertility, and should I consider preserving sperm or eggs before starting?
  5. 5.What is my long-term risk of a treatment-related leukemia or other late effects, and how will I be followed?

Last reviewed • Oct 2026

Educational content, not medical advice.